Influence of the use of oral contraceptives as risk factors for human papillomavirus infection and cervical intraepithelial neoplasia;Influencia del uso de anticonceptivos orales como factores de riesgo para infección por virus del papiloma humano y neoplasia intraepitelial cervical

Ginecologia y Obstetricia de Mexico

Volumn 73, Issue 2, 2005, Pages 83-89

  Salazar, Edith Lucía ^a,b   González, J Luis ^b   Olmos, Alejandro ^b   Calzada, Leobardo ^c  

^a Unidad de Investigación Médica en Enfermedades Endocrinas   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c Health Center (T III) Dr Manuel Escondria   (Mexico)

Author keywords

Human papillomavirus; Reproductive age; Viral oncogenes

Indexed keywords

ADULT; ARTICLE; BIRTH CONTROL; CANCER GRADING; CANCER GROWTH; COLPOSCOPY; CONTROLLED STUDY; CYTOLOGY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; PREGNANCY; RISK FACTOR; SEXUAL BEHAVIOR; UTERINE CERVIX CARCINOMA IN SITU; VIRUS INFECTION; WART VIRUS;

ADULT; AGE FACTORS; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; CONTRACEPTIVES, ORAL, HORMONAL; CROSS-SECTIONAL STUDIES; FEMALE; GENE EXPRESSION REGULATION, VIRAL; HUMANS; INCIDENCE; MEXICO; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PROSPECTIVE STUDIES; REPRODUCTIVE HISTORY; RISK FACTORS; SEXUAL BEHAVIOR; SEXUAL PARTNERS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 34248572609     PISSN: 03009041     EISSN: 03009041     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Olvera RA, Quiroz PS, Pérez LJCJ, De la Rosa MV. Displasia cervical y carcinoma cervicouterino: un reto para los servicios de salud. Ginec Obst Mex 1998;66:232-6.
2. Salud Pública de México 2004;46:165-85.
3. García SM. Frecuencia relativa del cáncer en el Hospital de Oncología. Rev Med del IMSS 1991;92:355-9.
4. Stephen AC, Nilof MJ. Cancer of the utherin cervix. N Engl J Med 1996;334:1030-6.
5. Verduzco RL, Palet GJA, Aguirre GH, González PE. Cancer cérvico uterino y edad. Ginec Obst Mex 1997;65:119-22.
6. Brisson J, Morin C, Fortier M, Roy M, Bouchard C, Leclerc J. Risk factors for cervical intraepithelial neoplasia: differences between low-and high-grade lesions. Am J Epidemiol 1994;40:700-10.
7. Jones CJ, Brinton LA, Hamman RF, Stolley PA, Lehman HF, Levine RS. Risk factors for in situ cervical cancer: results from a case-control study. Cancer Res 1990;50:3657-62.
8. Sánchez VJT, Torres EM, Tay ZJ, Ruiz SC, Romero CR. Frecuencia de la neoplasia intraepitelial del cuello uterino y factores de riesgo en mujeres de la Ciudad de México. Ginec Obst Mex 1996;65:3-7.
9. Schiffman MH, Haley NJ, Felton JS, Andrews AW, Kaslow RA, Lancaster WD. Biochemical epidemiology of cervical neoplasia: Measuring cigarette smoke constituents in the cervix. Cancer Res 1987;47:3886-88.
10. Tran-Thanh D, Provencher D, Kovshik A, Duarte-Franco E, Kessous A, Drovin P. Herpes simplex virus type II is not a cofactor to human papillomavirus in cancer of the uterine cervix. Am J Obstet Gynecol 2003;188:129-34.
11. Zur-Hauzen H. Human papillomavirus in the pathogenesis of anogenital cancer. Virology 1991;184:9-13.
12. Altekruse SF, Lacey JV Jr, Brinton LA, Gravitt PE, Silverberg SG, Barnes WA. Comparison of human papillomavirus genotypes, sexual, and reproductive risk factors of cervical adenocarcinoma and squamous cell carcinoma: Northestern United States. Obstet Gynecol 2003;188:657-63.
13. De Villiers EM. Relationship between steroid hormone contraceptives and HPV, cervical intraepithelial neoplasia and cervical carcinoma. Int J Cancer 2003;103:705-9.
14. Salazar EL, Sojo AI, López R. The evidence of an etiological relationship between oral contraceptive use and dysplasic changes in cervical tissue. Gynecol Endocrinol 2000;13:1-6.
15. Pater MM, Mittal R, Pater A. Role of steroid hormones in potentiating transformation of cervical cells by human papillomavirus. Trends Microbiol 1994;2:229-35.
16. Pater A, Bayatpour M, Pater MM. Oncogenic transformation by human papillomavirus type 16 deoxyribonucleic acid in the presence of progesterone or progestins from oral contraceptives. Am J Obstet Gynec 1990;162:1099-103.
17. Salazar EL, Mercado PE, Sojo AI. Relationship between estradiol 16α-hydroxylation and human papillomavirus infection in cervical cell transformation. Gynecol Endocrinol 2001;15:335-40.
18. La Vecchia C, Tavani A, Franceschi S, Parazzini F. Oral contraceptive and cancer. A review of the evidence. Drugs Safety 1996;14:260-72.
19. Salazar EL, Roman MA, Gonzalez SJ. Progesterone receptor values in human papilloma virus infection and cervical intraepithelial neoplasia. Med Sci Res 1997;25:511-2.
20. Nonogaki H, Fujii S, Konishi I, Nanbu Y, Ozaki S, Ishikawa Y. Estrogen receptor localization in normal and neoplastic epithelium of the cervix. Cancer 1990;66:2620-7.
21. Berumen J, Casas L, Segura E, Amescua JL, Garcia-Carrancá. Genome amplification of human papillomavirus types 16 and 18 in cervical carcinomas is related to the retention of E1/E2 genes. Int J Cancer 1997;56:640-5.
22. Mitrani-Rosenbaum S, Tsvieli R, Tur-Kaspa R. Oestrogen stimulates differential transcription of human papillomavirus type 16 in SiHa cervical carcinoma cells. J Gen Virol 1989;70:2227-232.
23. Salazar EL, Roman AM, González SJ. Hormone receptors status in cervical intraepithelial neoplasia: correlation with the stage of disease. Med Sci Res 1999;27:681-3.
24. Brinton LA, Reeves WC, Brenes MM, Herrero R, Britton RC, Gaitan E. Oral contraceptive use and risk of invasive cervical cancer. Inter J Epidemiol 1990;19:4-11.
25. Salazar EL, Torres JA, Avila A, Andrade A. Hyperplastic changes and receptors status in the breast tissue of bodybuilders under anabolic-androgenic steroid stimulation. Arch Androl 2000;45:1-7.